Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Abacavir - Innovation Pharmaceuticals

Next Previous
Search
Drug Profile

Abacavir - Innovation Pharmaceuticals

Alternative Names: abacavir acetate - Innovation Pharmaceuticals; Abacavir hydroxyacetate - Innovation Pharmaceuticals; KM-133; Prurisol

Latest Information Update: 20 Jan 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Unknown
  • Developer Innovation Pharmaceuticals
  • Class Antipsoriatics; Antiretrovirals; Cyclopentanes; Cyclopropanes; Dideoxynucleosides; Small molecules
  • Mechanism of Action HIV replication inhibitors; Immunomodulators; Nucleoside reverse transcriptase inhibitors; PRINS expression inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Psoriasis

Highest Development Phases

  • Discontinued Plaque psoriasis

Most Recent Events

  • 30 Jun 2019 Discontinued - Phase-II for Plaque psoriasis in USA (PO) (strategic focus on other assets)
  • 15 Oct 2018 Abacavir is still in phase II development for Plaque psoriasis in USA (Innovation Pharmaceuticals pipeline, October 2018)
  • 31 Dec 2017 Innovation Pharmaceuticals completes a phase IIb trial in Plaque psoriasis in USA (NCT02949388)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top